Atopic Dermatitis

Higher dietary sodium intake was associated with a higher risk for current atopic dermatitis, suggesting that a sodium-restricting diet may be a helpful intervention for disease management, according to a study.

Vaccinations can be safe and effective during dupilumab treatment, according to the consensus of a panel published in Annals of Allergy, Asthma & Immunology.

Due to medical advancements, researchers are calling for an update to the U.S. Department of Defense’s policies restricting individuals with psoriasis and atopic dermatitis from joining and remaining in the military, according to a study.

Adults treated with amlitelimab showed sustained improvement in their moderate to severe atopic dermatitis over the span of 28 weeks, Sanofi announced in a press release.

The FDA has cleared InnoCare Pharma’s investigational new drug application for ICP-332, according to a press release.

In order to better manage symptoms of atopic dermatitis, health care professionals must consider aggravating factors and systemic immunotherapy, according to a study published in the Chinese Medical Journal.

Roflumilast cream 0.15% demonstrated long-term efficacy and tolerability in adults and children aged 6 years and older with atopic dermatitis, Arcutis announced in a press release.

CLEVELAND — For patients with atopic dermatitis, today’s systemic therapies can lead to long-standing on-drug relief, but long-term, off-drug remission remains a goal that has yet to be reached, according to Raj Chovatiya, MD, PhD.

Dermatologist Raj Chovatiya, MD, PhD, MSCI, recently spoke to Healio about his new findings in seborrheic dermatitis and how to best treat diverse patient groups with this condition.

Topical tapinarof cream showed significant improvement of moderate to severe atopic dermatitis while being well tolerated by adults and children down to age 2 years, according to two phase 3 clinical trials.